Harold Jacob

Harold Jacob appears in our data through filings on Oramed Pharmaceuticals Inc. shares, published by SEC (Form 4). The record holds 5 filings, for trades running from 30 December 2013 to 10 March 2016.

Both buying and selling appear: 1 purchase worth €7,300, against 2 sales worth €59k. On balance, insiders were net sellers of €52k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. Since January 2016: no purchases and 1 sale on the market.

The latest filing, published on 14 March 2016, reports an open-market sale of €50k in Oramed Pharmaceuticals Inc. The clock since the last published purchase (18 April 2014) now reads 4,588 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.